Assessing Pharmacokinetics in Liver Disease: Challenges and Future Considerations for Classification of Hepatic Dysfunction and Use of In Silico Methods.

Journal of clinical pharmacology(2023)

引用 1|浏览10
暂无评分
摘要
All authors declared no competing interests for this work. Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
更多
查看译文
关键词
dosing,hepatic impairment,liver disease,pharmacokinetics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要